Valuation: TAKE LIMITED

Market Cap 5.86B 61.25M 52.45M 48.93M 44.9M 84.37M 86.03M 581M 226M 2.94B 230M 225M 9.72B P/E 2024
-2.54x
P/E 2025 2.61x
Enterprise Value 5.83B 60.9M 52.14M 48.65M 44.64M 83.89M 85.54M 577M 225M 2.92B 229M 224M 9.67B EV / Sales 2024
5.18x
EV / Sales 2025 -
Free-Float
40.47%
Yield 2024 *
-
Yield 2025 -
1 day-4.59%
1 week-7.22%
Current month+1.96%
1 month+14.65%
3 months-14.45%
6 months-53.80%
Current year-45.32%
1 week 21.75
Extreme 21.75
24.3
1 month 19.82
Extreme 19.82
24.39
Current year 18.57
Extreme 18.57
50.14
1 year 9.9
Extreme 9.9
50.14
3 years 6.51
Extreme 6.51
50.14
5 years 6.51
Extreme 6.51
55.6
10 years 6.51
Extreme 6.51
308.25
Manager TitleAgeSince
Compliance Officer - 2026-01-27
Chief Tech/Sci/R&D Officer 56 -
Director TitleAgeSince
Director/Board Member - 2025-05-23
Director/Board Member 43 2025-05-23
Director/Board Member 47 2025-05-23
Change 5-day change 1-year change 3-year change Capi.($)
-4.59%-7.22%+107.80%+21.33% 35.43M
+1.14%+2.27%+2.38%+24.66% 50.5B
-1.67%+4.41%+483.24%+606.06% 46.01B
-1.18%+4.58%+20.36%+89.83% 42.85B
+3.71%+7.23%+34.86%+20.82% 41.03B
0.00%-3.91%+17.87%+47.98% 32.02B
+2.16%+6.56%+33.15%+152.10% 16.98B
-1.27%+4.27% - - 17.05B
+3.06%+3.88%+5.81%+35.45% 14.3B
+1.86%+5.17%+85.36%+47.23% 13.84B
Average +0.36%+1.53%+87.87%+116.16% 27.46B
Weighted average by Cap. +0.67%+2.37%+105.06%+151.86%

Financials

2024 2025
Net sales 656M 6.86M 5.87M 5.48M 5.03M 9.44M 9.63M 64.98M 25.33M 329M 25.75M 25.19M 1.09B -
Net income -1.2B -12.5M -10.7M -9.99M -9.16M -17.22M -17.56M -118M -46.18M -599M -46.94M -45.92M -1.98B 375M 3.92M 3.35M 3.13M 2.87M 5.39M 5.5M 37.11M 14.47M 188M 14.7M 14.38M 622M
Net Debt 362M 3.79M 3.24M 3.03M 2.78M 5.22M 5.32M 35.89M 13.99M 182M 14.22M 13.91M 601M -33.71M -352K -302K -281K -258K -485K -495K -3.34M -1.3M -16.89M -1.32M -1.29M -55.93M
Logo TAKE LIMITED
Take Solutions Limited is an India-based contract research organization (CRO), which is engaged in supporting pharma, biotech and devices companies. The Company offers clients a combination of full-service clinical research, generics development, data sciences, regulatory affairs, and pharmacovigilance/safety services. Its range of services span from clinical trials to regulatory submissions to post-marketing safety, all backed by insights derived through proprietary industry network forums. Its digital healthcare services include medical decision-making (artificial intelligence and machine learning), and cloud adoption & mobility. Its global roster of clients includes large and small biopharmaceutical and device companies, United States federal agencies like Centers for Disease Control and Prevention (CDC) and the United States Department of Defense (DoD), as well as generics manufacturers. The Company's subsidiary is Ecron Acunova Limited.
Employees
2
Date Price Change Volume
26-08-20 21.84 -4.59% 689,149
26-08-19 ₹22.89 -1.80% 1,213,425
26-08-18 ₹23.31 -0.51% 1,387,761
26-08-17 ₹23.43 -1.39% 1,251,379
26-08-14 ₹23.76 +0.21% 1,451,037
  1. Stock Market
  2. Stocks
  3. TAKE Stock